Cargando…
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443371/ https://www.ncbi.nlm.nih.gov/pubmed/32830309 http://dx.doi.org/10.1007/s11239-020-02251-z |
| _version_ | 1783573621473542144 |
|---|---|
| author | McGlynn, Fergal McGrath, Jennifer Varghese, Chithra Ryan, Barbara McHugh, Johnny Fahy, Arabella Enright, Helen |
| author_facet | McGlynn, Fergal McGrath, Jennifer Varghese, Chithra Ryan, Barbara McHugh, Johnny Fahy, Arabella Enright, Helen |
| author_sort | McGlynn, Fergal |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7443371 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74433712020-08-24 Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection McGlynn, Fergal McGrath, Jennifer Varghese, Chithra Ryan, Barbara McHugh, Johnny Fahy, Arabella Enright, Helen J Thromb Thrombolysis Letter to the Editor Springer US 2020-08-24 2021 /pmc/articles/PMC7443371/ /pubmed/32830309 http://dx.doi.org/10.1007/s11239-020-02251-z Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor McGlynn, Fergal McGrath, Jennifer Varghese, Chithra Ryan, Barbara McHugh, Johnny Fahy, Arabella Enright, Helen Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title | Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title_full | Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title_fullStr | Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title_full_unstemmed | Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title_short | Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection |
| title_sort | argatroban for therapeutic anticoagulation for heparin resistance associated with covid-19 infection |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443371/ https://www.ncbi.nlm.nih.gov/pubmed/32830309 http://dx.doi.org/10.1007/s11239-020-02251-z |
| work_keys_str_mv | AT mcglynnfergal argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT mcgrathjennifer argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT varghesechithra argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT ryanbarbara argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT mchughjohnny argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT fahyarabella argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection AT enrighthelen argatrobanfortherapeuticanticoagulationforheparinresistanceassociatedwithcovid19infection |